Key Financial Data Of Reporting Company

Chiome Bioscience Inc. - Filing #7571351

Concept As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2019-12-31
2019-01-01 to
2019-12-31
As at
2018-12-31
2018-01-01 to
2018-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
630,815,000 JPY
712,932,000 JPY
480,853,000 JPY
447,576,000 JPY
212,851,000 JPY
Ordinary profit (loss)
-1,243,838,000 JPY
-1,329,312,000 JPY
-1,291,606,000 JPY
-1,410,314,000 JPY
-1,533,952,000 JPY
Profit (loss)
-1,242,871,000 JPY
-1,479,895,000 JPY
-1,293,798,000 JPY
-1,403,821,000 JPY
-1,533,502,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
JPY
JPY
Share capital
2,097,017,000 JPY
1,515,929,000 JPY
1,387,677,000 JPY
6,132,216,000 JPY
5,454,775,000 JPY
Total number of issued shares
48,423,500 xbrli:shares
40,781,500 xbrli:shares
39,505,200 xbrli:shares
33,283,500 xbrli:shares
26,781,500 xbrli:shares
Net assets
1,790,746,000 JPY
1,893,049,000 JPY
3,109,968,000 JPY
2,621,508,000 JPY
2,676,719,000 JPY
Total assets
2,215,470,000 JPY
2,339,439,000 JPY
3,494,554,000 JPY
2,808,090,000 JPY
2,831,193,000 JPY
Net assets per share
36.70
45.55
77.99
78.10
98.89
Dividend paid per share
Interim dividend paid per share
Basic earnings (loss) per share
-28.26
-36.74
-36.06
-44.61
-57.26
Diluted earnings per share
Equity-to-asset ratio
0.802 xbrli:pure
0.794 xbrli:pure
0.882 xbrli:pure
0.926 xbrli:pure
0.935 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-1,191,009,000 JPY
-1,131,291,000 JPY
-1,360,143,000 JPY
-1,537,360,000 JPY
-1,688,713,000 JPY
Net cash provided by (used in) investing activities
JPY
-35,384,000 JPY
-3,519,000 JPY
-26,423,000 JPY
JPY
Net cash provided by (used in) financing activities
1,127,291,000 JPY
271,345,000 JPY
1,944,005,000 JPY
1,341,245,000 JPY
-10,239,000 JPY
Cash and cash equivalents
1,727,270,000 JPY
1,790,988,000 JPY
2,686,318,000 JPY
2,105,976,000 JPY
2,328,513,000 JPY
Number of employees
39 xbrli:pure
10 xbrli:pure
49 xbrli:pure
49 xbrli:pure
42 xbrli:pure
38 xbrli:pure
37 xbrli:pure
Average number of temporary employees
10 xbrli:pure
4 xbrli:pure
14 xbrli:pure
13 xbrli:pure
14 xbrli:pure
14 xbrli:pure
10 xbrli:pure
Total shareholder return
0.510 xbrli:pure
0.559 xbrli:pure
0.533 xbrli:pure
0.579 xbrli:pure
0.539 xbrli:pure
Total return on share price index
0.762 xbrli:pure
0.811 xbrli:pure
0.982 xbrli:pure
0.737 xbrli:pure
0.667 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.